Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study. (linkinghub.elsevier.com)

Authors: Lund LH … Petrie MC Journal: The Lancet Published: 2026-06-24 DOI: https://doi.org/10.1016/S0140-6736(26)00904-9